‘Covishield’ could Launch In November

As per the latest news reports, Adar Poonawalla, CEO of the world’s largest vaccine manufacturer –  Serum Institute of India (SII), shared that the Oxford Coronavirus Vaccine, whose results of Phase I, II trials have appeared safe, will be called ‘Covishield’ in India. He said that SII has sought an official approval from the Drug…